Timothy Babinchak

3.0k total citations
31 papers, 1.9k citations indexed

About

Timothy Babinchak is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Timothy Babinchak has authored 31 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Medicine, 13 papers in Pharmacology and 11 papers in Epidemiology. Recurrent topics in Timothy Babinchak's work include Antibiotic Resistance in Bacteria (15 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Antibiotic Use and Resistance (8 papers). Timothy Babinchak is often cited by papers focused on Antibiotic Resistance in Bacteria (15 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Antibiotic Use and Resistance (8 papers). Timothy Babinchak collaborates with scholars based in United States, Canada and Romania. Timothy Babinchak's co-authors include Evelyn J. Ellis‐Grosse, Nathalie Dartois, Gilbert M. Rose, Evan Loh, Gary E. Stein, H. Lode, Gary Dukart, Mark L. Metersky, R.G. Masterton and Thomas M. File and has published in prestigious journals such as Clinical Infectious Diseases, CHEST Journal and The Journal of Infectious Diseases.

In The Last Decade

Timothy Babinchak

29 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy Babinchak United States 17 949 733 673 540 421 31 1.9k
Valerio Del Bono Italy 32 1.0k 1.1× 639 0.9× 962 1.4× 1.4k 2.5× 442 1.0× 80 2.8k
Yu‐Chung Chuang Taiwan 27 613 0.6× 294 0.4× 909 1.4× 1.0k 1.9× 373 0.9× 122 2.3k
H Drugeon France 20 633 0.7× 363 0.5× 694 1.0× 534 1.0× 263 0.6× 76 1.7k
Shirish Huprikar United States 24 761 0.8× 378 0.5× 886 1.3× 1.8k 3.3× 187 0.4× 80 2.9k
Sorana Segal‐Maurer United States 22 466 0.5× 254 0.3× 707 1.1× 593 1.1× 176 0.4× 63 1.6k
Gopi Patel United States 24 1.5k 1.6× 653 0.9× 687 1.0× 1.1k 2.0× 366 0.9× 81 2.7k
Simon Portsmouth United States 24 856 0.9× 635 0.9× 786 1.2× 1.5k 2.7× 97 0.2× 62 2.9k
Fabio Tumietto Italy 23 1.1k 1.1× 534 0.7× 404 0.6× 859 1.6× 299 0.7× 53 2.1k
Claude Carbón France 27 498 0.5× 699 1.0× 735 1.1× 1.1k 2.0× 290 0.7× 91 2.6k
Joan R. Butterton United States 32 791 0.8× 610 0.8× 1.1k 1.6× 1.2k 2.3× 93 0.2× 87 3.1k

Countries citing papers authored by Timothy Babinchak

Since Specialization
Citations

This map shows the geographic impact of Timothy Babinchak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Babinchak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Babinchak more than expected).

Fields of papers citing papers by Timothy Babinchak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Babinchak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Babinchak. The network helps show where Timothy Babinchak may publish in the future.

Co-authorship network of co-authors of Timothy Babinchak

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Babinchak. A scholar is included among the top collaborators of Timothy Babinchak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Babinchak. Timothy Babinchak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stein, Gary E. & Timothy Babinchak. (2013). Tigecycline: an update. Diagnostic Microbiology and Infectious Disease. 75(4). 331–336. 150 indexed citations
2.
Rahav, Galia, Edward T. Zito, David Gardiner, et al.. (2012). A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections. BMC Infectious Diseases. 12(1). 297–297. 27 indexed citations
3.
Metersky, Mark L., R.G. Masterton, H. Lode, Thomas M. File, & Timothy Babinchak. (2012). Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza. International Journal of Infectious Diseases. 16(5). e321–e331. 168 indexed citations
4.
Gardiner, David, Gary Dukart, Angel Cooper, & Timothy Babinchak. (2009). Safety and Efficacy of Intravenous Tigecycline in Subjects with Secondary Bacteremia: Pooled Results from 8 Phase III Clinical Trials. Clinical Infectious Diseases. 50(2). 229–238. 73 indexed citations
5.
Ambrose, Paul G., Alison Meagher, Julie Passarell, et al.. (2008). Use of a clinically derived exposure–response relationship to evaluate potential tigecycline-Enterobacteriaceae susceptibility breakpoints. Diagnostic Microbiology and Infectious Disease. 63(1). 38–42. 13 indexed citations
6.
7.
8.
Cooper, Angel, et al.. (2008). The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra-Adominal Infections - The European Experience. Journal of Chemotherapy. 20(sup1). 12–19. 16 indexed citations
9.
Gardiner, David, et al.. (2006). Mortality and Gram-negative rod bacteraemia in the intensive care unit. Journal of Hospital Infection. 62(4). 453–457. 9 indexed citations
10.
11.
12.
DeSimone, Joseph, Timothy Babinchak, K Kaulback, & Roger J. Pomerantz. (2003). Treatment of Mycobacterium avium Complex Immune Reconstitution Disease in HIV-1-Infected Individuals. AIDS Patient Care and STDs. 17(12). 617–622. 16 indexed citations
13.
Babinchak, Timothy. (2002). Causes of Common Illnesses: An Overview. The Journal of School Nursing. 18(5_suppl). 8–11.
14.
Yakulis, Robert & Timothy Babinchak. (1999). Herpes Simplex Peritonitis: Case Report. Clinical Infectious Diseases. 28(6). 1212–1215. 7 indexed citations
15.
Riley, Deborah K., et al.. (1997). Infectious Complications of Hepatic Cryosurgery. Clinical Infectious Diseases. 24(5). 1001–1003. 12 indexed citations
16.
Babinchak, Timothy, et al.. (1997). Pyogenic Vertebral Osteomyelitis of the Posterior Elements. Clinical Infectious Diseases. 25(2). 221–224. 43 indexed citations
17.
Babinchak, Timothy. (1995). Oral Ciprofloxacin Therapy for Prosthetic Valve Endocarditis Due to Actinobacillus actinomycetemcomitans. Clinical Infectious Diseases. 21(6). 1517–1518. 8 indexed citations
18.
Babinchak, Timothy, et al.. (1994). Patients Treated by a Thoracic Surgeon With HIV. CHEST Journal. 106(3). 681–683.
19.
Babinchak, Timothy & Robert J. Fass. (1992). In vitro activity of DNA gyrase inhibitors, singly and in combination, against Mycobacterium avium complex. Diagnostic Microbiology and Infectious Disease. 15(4). 367–370. 4 indexed citations
20.
Babinchak, Timothy & Robert J. Fass. (1989). Quinolone antibacterial agents for the treatment of genitourinary tract infections. European Journal of Clinical Microbiology & Infectious Diseases. 8(12). 1111–1116. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valerio Del Bono Breakdown of academic impact, for papers by Yu‐Chung Chuang Breakdown of academic impact, for papers by H Drugeon Breakdown of academic impact, for papers by Shirish Huprikar Breakdown of academic impact, for papers by Sorana Segal‐Maurer Breakdown of academic impact, for papers by Gopi Patel Breakdown of academic impact, for papers by Simon Portsmouth Breakdown of academic impact, for papers by Fabio Tumietto Breakdown of academic impact, for papers by Claude Carbón Breakdown of academic impact, for papers by Joan R. Butterton
Rankless by CCL
2026